Posterior reversible encephalopathy syndrome

Takao Yasuhara, Koji Tokunaga, Tomohito Hishikawa, Shigeki Ono, Yasuyuki Miyoshi, Kenji Sugiu, Isao Date

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Posterior reversible encephalopathy syndrome (PRES) is a clinico-neuroradiological entity with typical symptoms and symmetric high-signal intensity lesions in the bilateral parieto-occipital lobes on T2-weighted or fluid-attenuated inversion recovery (FLAIR) MRI. We described three patients with PRES of varied etiologies. Patient 1 was a young man with severe hypertension who presented with headache and visual disturbance. Patient 2 had leukemia and was receiving umbilical cord blood cell transplantation with immunosuppressant, and developed PRES with convulsions. Patient 3 was a pregnant woman with renal failure, who repeatedly developed PRES with convulsions. FLAIR and apparent diffusion coefficient mapping were useful in detecting PRES lesions in our patients, although diffusion-weighted imaging and CT scans had limited use in the diagnosis. Adequate and prompt treatment with antihypertensive medication immediately ameliorated the symptoms, with improvement of abnormal MRI findings. In previous reports, delayed diagnosis might have affected the prognosis. Further work on the clinical manifestations of PRES and its therapy is required.

Original languageEnglish
Pages (from-to)406-409
Number of pages4
JournalJournal of Clinical Neuroscience
Volume18
Issue number3
DOIs
Publication statusPublished - Mar 2011

Fingerprint

Posterior Leukoencephalopathy Syndrome
Seizures
Occipital Lobe
Delayed Diagnosis
Cell Transplantation
Immunosuppressive Agents
Fetal Blood
Antihypertensive Agents
Renal Insufficiency
Headache
Pregnant Women
Blood Cells
Leukemia
Hypertension
Therapeutics

Keywords

  • Apparent diffusion coefficient
  • Eclampsia
  • Fluid-attenuated inversion recovery MRI
  • Hypertension
  • Immunosuppressant
  • MRI
  • Posterior reversible encephalopathy syndrome

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Physiology (medical)

Cite this

Posterior reversible encephalopathy syndrome. / Yasuhara, Takao; Tokunaga, Koji; Hishikawa, Tomohito; Ono, Shigeki; Miyoshi, Yasuyuki; Sugiu, Kenji; Date, Isao.

In: Journal of Clinical Neuroscience, Vol. 18, No. 3, 03.2011, p. 406-409.

Research output: Contribution to journalArticle

Yasuhara, Takao ; Tokunaga, Koji ; Hishikawa, Tomohito ; Ono, Shigeki ; Miyoshi, Yasuyuki ; Sugiu, Kenji ; Date, Isao. / Posterior reversible encephalopathy syndrome. In: Journal of Clinical Neuroscience. 2011 ; Vol. 18, No. 3. pp. 406-409.
@article{5cd1748f0f62488cb0b97cf63ee842b5,
title = "Posterior reversible encephalopathy syndrome",
abstract = "Posterior reversible encephalopathy syndrome (PRES) is a clinico-neuroradiological entity with typical symptoms and symmetric high-signal intensity lesions in the bilateral parieto-occipital lobes on T2-weighted or fluid-attenuated inversion recovery (FLAIR) MRI. We described three patients with PRES of varied etiologies. Patient 1 was a young man with severe hypertension who presented with headache and visual disturbance. Patient 2 had leukemia and was receiving umbilical cord blood cell transplantation with immunosuppressant, and developed PRES with convulsions. Patient 3 was a pregnant woman with renal failure, who repeatedly developed PRES with convulsions. FLAIR and apparent diffusion coefficient mapping were useful in detecting PRES lesions in our patients, although diffusion-weighted imaging and CT scans had limited use in the diagnosis. Adequate and prompt treatment with antihypertensive medication immediately ameliorated the symptoms, with improvement of abnormal MRI findings. In previous reports, delayed diagnosis might have affected the prognosis. Further work on the clinical manifestations of PRES and its therapy is required.",
keywords = "Apparent diffusion coefficient, Eclampsia, Fluid-attenuated inversion recovery MRI, Hypertension, Immunosuppressant, MRI, Posterior reversible encephalopathy syndrome",
author = "Takao Yasuhara and Koji Tokunaga and Tomohito Hishikawa and Shigeki Ono and Yasuyuki Miyoshi and Kenji Sugiu and Isao Date",
year = "2011",
month = "3",
doi = "10.1016/j.jocn.2010.06.011",
language = "English",
volume = "18",
pages = "406--409",
journal = "Journal of Clinical Neuroscience",
issn = "0967-5868",
publisher = "Churchill Livingstone",
number = "3",

}

TY - JOUR

T1 - Posterior reversible encephalopathy syndrome

AU - Yasuhara, Takao

AU - Tokunaga, Koji

AU - Hishikawa, Tomohito

AU - Ono, Shigeki

AU - Miyoshi, Yasuyuki

AU - Sugiu, Kenji

AU - Date, Isao

PY - 2011/3

Y1 - 2011/3

N2 - Posterior reversible encephalopathy syndrome (PRES) is a clinico-neuroradiological entity with typical symptoms and symmetric high-signal intensity lesions in the bilateral parieto-occipital lobes on T2-weighted or fluid-attenuated inversion recovery (FLAIR) MRI. We described three patients with PRES of varied etiologies. Patient 1 was a young man with severe hypertension who presented with headache and visual disturbance. Patient 2 had leukemia and was receiving umbilical cord blood cell transplantation with immunosuppressant, and developed PRES with convulsions. Patient 3 was a pregnant woman with renal failure, who repeatedly developed PRES with convulsions. FLAIR and apparent diffusion coefficient mapping were useful in detecting PRES lesions in our patients, although diffusion-weighted imaging and CT scans had limited use in the diagnosis. Adequate and prompt treatment with antihypertensive medication immediately ameliorated the symptoms, with improvement of abnormal MRI findings. In previous reports, delayed diagnosis might have affected the prognosis. Further work on the clinical manifestations of PRES and its therapy is required.

AB - Posterior reversible encephalopathy syndrome (PRES) is a clinico-neuroradiological entity with typical symptoms and symmetric high-signal intensity lesions in the bilateral parieto-occipital lobes on T2-weighted or fluid-attenuated inversion recovery (FLAIR) MRI. We described three patients with PRES of varied etiologies. Patient 1 was a young man with severe hypertension who presented with headache and visual disturbance. Patient 2 had leukemia and was receiving umbilical cord blood cell transplantation with immunosuppressant, and developed PRES with convulsions. Patient 3 was a pregnant woman with renal failure, who repeatedly developed PRES with convulsions. FLAIR and apparent diffusion coefficient mapping were useful in detecting PRES lesions in our patients, although diffusion-weighted imaging and CT scans had limited use in the diagnosis. Adequate and prompt treatment with antihypertensive medication immediately ameliorated the symptoms, with improvement of abnormal MRI findings. In previous reports, delayed diagnosis might have affected the prognosis. Further work on the clinical manifestations of PRES and its therapy is required.

KW - Apparent diffusion coefficient

KW - Eclampsia

KW - Fluid-attenuated inversion recovery MRI

KW - Hypertension

KW - Immunosuppressant

KW - MRI

KW - Posterior reversible encephalopathy syndrome

UR - http://www.scopus.com/inward/record.url?scp=79551548896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79551548896&partnerID=8YFLogxK

U2 - 10.1016/j.jocn.2010.06.011

DO - 10.1016/j.jocn.2010.06.011

M3 - Article

C2 - 21236681

AN - SCOPUS:79551548896

VL - 18

SP - 406

EP - 409

JO - Journal of Clinical Neuroscience

JF - Journal of Clinical Neuroscience

SN - 0967-5868

IS - 3

ER -